Last updated on November 2017

The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension


Brief description of study

The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension

Detailed Study Description

This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.

Clinical Study Identifier: TX82167

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Angela Smit, CCRP

Clinical Eye Research Center of Connecticut
Danbury, CT USA
  Connect »